Literature DB >> 20447322

Validation of the Spanish version of the DEMQOL system.

Ramona Lucas-Carrasco1, Donna L Lamping, Sube Banerjee, Javier Rejas, Sarah C Smith, Juana Gómez-Benito.   

Abstract

BACKGROUND: Dementia is associated with poor quality of life, but generic measures do not fully capture main aspects of these conditions. Our aim was to validate a Spanish version of the "dementia-specific health-related quality of life" DEMQOL system.
METHODS: We validated the Spanish DEMQOL and DEMQOL-Proxy in 119 people with dementia from six centers and their caregivers. Patient-reported information, including generic (WHOQOL-BREF) and dementia-specific (DEMQOL) health-related quality of life, depressive symptoms (GDS-15), functional ability (Barthel Index), subjective perception of health and demographic information, was obtained by interview. Proxy-reported information from a family caregiver about the patient's quality of life (DEMQOL-Proxy) was also obtained by interview.
RESULTS: The Spanish DEMQOL showed good psychometric properties. Acceptability (14.3% missing data), internal consistency (Cronbach's alpha = 0.85) and test-retest reliability (ICC = 0.71) were good. A priori hypotheses about the relationship between DEMQOL and the WHOQOL-BREF (psychological and physical domains), GDS-15 and Barthel Index were confirmed, indicating good construct validity. Associations between DEMQOL-Proxy and other measures were weaker. A three-factor solution accounted for 44.4% of the total variance of DEMQOL, and a four-factor solution accounted for 53.3% of the total variance of DEMQOL- Proxy.
CONCLUSION: The Spanish versions of DEMQOL and DEMQOL-Proxy are reliable and valid in patients with mild/moderate dementia who are living at home.

Entities:  

Mesh:

Year:  2010        PMID: 20447322     DOI: 10.1017/S1041610210000207

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  7 in total

1.  Addressing the bias problem in the assessment of the quality of life of patients with dementia: determinants of the accuracy and precision of the proxy ratings.

Authors:  M Gomez-Gallego; J Gomez-Garcia; E Ato-Lozano
Journal:  J Nutr Health Aging       Date:  2015-03       Impact factor: 4.075

2.  Italian validation of the DEMQOL-PROXY: Exploratory Factor Analysis, Convergent and Divergent Validity.

Authors:  Alessandra Miraglia Raineri; Chiara Bonfigliuoli; Massimo Guasconi; Francesca Camaiani; Giovanna Artioli; Leopoldo Sarli
Journal:  Acta Biomed       Date:  2022-05-12

3.  Item distribution, internal consistency, and structural validity of the German version of the DEMQOL and DEMQOL-proxy.

Authors:  Christian G G Schwab; Martin Nikolaus Dichter; Martin Berwig
Journal:  BMC Geriatr       Date:  2018-10-19       Impact factor: 3.921

4.  Adaptation of the DEMQOL-Proxy for routine use in care homes: a cross-sectional study of the reliability and validity of DEMQOL-CH.

Authors:  Laura J Hughes; Nicolas Farina; Thomas E Page; Naji Tabet; Sube Banerjee
Journal:  BMJ Open       Date:  2019-08-08       Impact factor: 2.692

5.  Italian pilot version of DEMOQL-PROXY: Content and Face validity: a methodological bridge for a future Italian validation.

Authors:  Alessandra Miraglia Raineri; Chiara Bonfigliuoli; Francesca Camaiani; Leopoldo Sarli; Giovanna Artioli
Journal:  Acta Biomed       Date:  2020-06-20

6.  Health-related quality of life in the Cambridge City over-75s Cohort (CC75C): development of a dementia-specific scale and descriptive analyses.

Authors:  Jaime Perales; Theodore D Cosco; Blossom C M Stephan; Jane Fleming; Steven Martin; Josep Maria Haro; Carol Brayne
Journal:  BMC Geriatr       Date:  2014-02-10       Impact factor: 3.921

7.  Quality-of-life assessment in dementia: the use of DEMQOL and DEMQOL-Proxy total scores.

Authors:  Kia-Chong Chua; Anna Brown; Ryan Little; David Matthews; Liam Morton; Vanessa Loftus; Caroline Watchurst; Rhian Tait; Renee Romeo; Sube Banerjee
Journal:  Qual Life Res       Date:  2016-06-18       Impact factor: 4.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.